Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine

Journal of Pathology

Volumn 184, Issue 1, 1998, Pages 71-76

  Heine, Bernhard ^a   Hummel, Michael ^a,b   Müller, Markus ^a   Heicappell, Rüdiger ^a   Miller, Kurt ^a   Stein, Harald ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Bladder carcinoma; Bladder washing; GeneScan; Telomerase activity; Telomeres; TRAP assay; Urine cytology

Indexed keywords

TELOMERASE;

ARTICLE; BLADDER CARCINOMA; BLADDER IRRIGATION; CANCER SCREENING; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; URINALYSIS; URINE CYTOLOGY;

EID: 0031885140     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9896(199801)184:1<71::aid-path988>3.0.co;2-%23     Document Type: Article

References (40)

1. Esposti PI, Moberger G, Zajicek J. The cytologic diagnosis of transitional cell tumors of the urinary bladder and its histologic basis. Acta Cytol (Baltimore) 1970; 14: 145-155.
2. Koss LG, Deitch D, Ramanathan R, Sherman AB. Diagnostic value of cytology in voided urine. Acta Cytol (Baltimore) 1985; 29: 810-816.
3. Wawroschek F, Rathert P. Urine cytology. Urologe A 1995; 34: 69-75.
4. Mollhof S, Rathert P. What is the value of urine cytology in after-care of patients with urothelial cancers? Urologe A 1992; 31: 203-205.
5. National Bladder Cancer Cooperative Group A. Cytology and histopathology of bladder cancer cases in a prospective longitudinal study. Cancer Res 1977; 37: 2911-2915.
6. Allshire RC, Gosden JR, Cross SH, et al. Telomeric repeat from T. thermophila cross hybridizes with human telomeres. Nature 1988; 332: 656-659.
7. Moyzis RK, Buckingham JM, Cram IS, et al. A highly conserved repetitive DNA sequence. (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6626.
8. Zakian V. Telomeres. Beginning to understand the end. Science 1995; 270: 1601-1607.
9. Chong L, Steensel B, Broccoli D, et al. A human telomeric protein. Science 1995; 270: 1663-1667.
10. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458-460.
11. Lindsey J, McGill NI, Lindsey LA, Green DK, Kooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991; 256: 45-48.
12. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
13. Allsopp RC, Chang E, Kashefi-Aazam M, et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995; 220: 194-200.
14. Rogan E, Bryan T, Hukku B, et al. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 1995; 15: 4745-4753.
15. Watson JD. Origin of concatemeric T7 DNA. Nature New Biol 1972; 239: 197-201.
16. Harley C. Telomere loss: mitotic clock or genetic time bomb. Mutat Res 1991; 256: 271-282.
17. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomeras activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68: 3410-3414.
18. Morin G. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-529.
19. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 1985; 43: 405-413.
20. Feng J, Funk W, Wang S, et al. The RNA component of human telomerase. Science 1995; 269: 1236-1241.
21. Shay J, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196: 33-39.
22. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995; 87: 884-894.
23. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
24. Hiyama E, Hiyama K, Yokohama T, Matsuura Y, Piatyszek M, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995; 1: 249-255.
25. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-2320.
26. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-2736.
27. Chadeneau C, Hay K, Hirte H, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-2536.
28. Counter C, Hirte H, Bacchetti S, Harley C. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91: 2900-2904.
29. Oral presentation by Professor J. Shay at the AACR Meeting 'Novel Strategies Against Resistant Cancers', Fort Myers, Florida. November 1995 and own unpublished data.
30. Mostofi F, Sobin L, Torloni H. International Histological Classification of Tumours (10): Histological Typing of Urinary Bladder Tumours. Geneva: World Health Organization, 1973.
31. Wright W, Shay J, Piatyszek M. Modifications of a telomerie repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794-3795.
32. Ohyashiki J, Ohyashiki K, Sano T, Toyama K. Non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Jpn J Cancer Res 1996; 87: 329-331.
33. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994; 9: 3043-3048.
34. Norrback KF, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996; 88: 222-229.
35. Morin G. Is telomerase a universal cancer target? J Natl Cancer Inst 1995; 87: 859-861.
36. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902.
37. Ohyashiki K, Ohyashiki J, Iwama H, Hayashi S, Shay J, Toyama K. Telomerase reactivation in leukemia cells. Int J Oncol 1996; 8: 417-421.
38. Lin Y, Miyamato H, Fujinami K, et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996; 2: 929-932.
39. Klinselhutz A, Foster S, McDougall J. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79-82.
40. Bryan T, Englezou A, Gupta J, Bacchetti S, Reddel R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14: 4240-4248.